NOS2 rs2297595: Understanding Your Genetic Variant
The rs2297595 variant is a specific change in the DNA sequence of the NOS2 gene, which provides instructions for making an enzyme involved in immune responses. This variant has been studied for its potential role in modulating nitric oxide production and influencing how the body responds to infections like malaria.
What each genotype means
Baseline nitric oxide production
This genotype represents the common homozygous state for the NOS2 variant. Research into this specific site suggests it may influence how your body regulates nitric oxide production during inflammatory responses, though the clinical impact remains limited and requires further study.
This genotype is common globally, though exact frequencies vary significantly by ancestral background.
Altered inflammatory response potential
Carrying one copy of the G allele may be associated with variations in nitric oxide synthase activity. Some studies have explored whether this variant influences susceptibility to inflammatory conditions or resistance to severe malaria, but current evidence is limited and not sufficient for clinical decision-making.
This heterozygous genotype is found in a significant portion of the population, consistent with the reported minor allele frequency of 0.15-0.30.
Variant-associated inflammatory profile
This homozygous genotype represents the less common variant state at this position in the NOS2 gene. While some research links this variant to altered inflammatory responses or malaria protection, these associations are not definitive and should not be used to predict individual health outcomes.
This genotype is less common than the A/A or A/G states, occurring at frequencies consistent with the reported minor allele distribution.
What is rs2297595?
The rs2297595 variant is a single nucleotide polymorphism (SNP) located within the NOS2 gene. A SNP is a common type of genetic variation where a single "letter" in the DNA code—a nucleotide—differs between individuals. The NOS2 gene is situated on chromosome 17 and encodes the inducible nitric oxide synthase enzyme, often referred to as iNOS. This enzyme is a critical component of the human immune system, responsible for producing nitric oxide, a signaling molecule that helps the body fight off pathogens and regulate inflammation. Because rs2297595 is located in a region that can influence gene expression, researchers investigate whether this specific change alters the amount or activity of the iNOS enzyme produced during an immune challenge. Understanding such variants helps scientists map the complex relationship between our genetic blueprint and our physiological responses to environmental stressors.
The Role of the NOS2 Gene
The NOS2 gene is essential for the production of nitric oxide (NO) in response to inflammatory stimuli, such as bacterial toxins or cytokines. Unlike other forms of nitric oxide synthase that are constantly active, the inducible form (iNOS) is typically "switched on" only when the immune system needs to defend the body. Once activated, iNOS produces high levels of nitric oxide, which acts as a potent antimicrobial agent, helping to kill invading microorganisms and modulate the behavior of immune cells like macrophages. Because nitric oxide is a powerful molecule, its production must be tightly regulated; too little might leave the body vulnerable to infection, while too much can contribute to excessive inflammation or tissue damage. Variations in the NOS2 gene, such as rs2297595, are of interest because they may shift this delicate balance, potentially affecting how effectively an individual manages inflammatory processes.
Research and Evidence Strength
Research into rs2297595 and other NOS2 variants has primarily focused on their association with infectious diseases, particularly malaria. Some studies have suggested that certain genetic profiles in the NOS2 gene may be linked to protection against severe forms of malaria, likely by influencing the body's ability to produce nitric oxide during the early stages of infection. However, the evidence for any single variant, including rs2297595, remains limited. Genetic associations are often complex and can vary significantly depending on the population studied, the specific strain of the pathogen, and other environmental factors. While some findings indicate a potential link to altered inflammatory responses, these results are not always consistent across different research cohorts. Consequently, while the biological role of the NOS2 gene is well-established, the clinical significance of this specific SNP is still an area of active scientific inquiry rather than a settled medical fact.
Population Frequency
The rs2297595 variant is found globally, with a minor allele frequency typically ranging between 0.15 and 0.30 across various ancestral populations. This means that the variant is relatively common, appearing in a significant portion of the human population. Because it is not rare, it is considered a common genetic polymorphism. The distribution of this variant can vary by geography and ancestry, which is a common observation in human genetics. Researchers often look at these frequency differences to understand how evolutionary pressures, such as historical exposure to infectious diseases, may have shaped the genetic diversity we see today. Because the frequency is relatively high, it is likely that this variant has been present in human populations for a long time, though its specific impact on health outcomes continues to be studied in diverse groups.
Interpreting Your Genetic Information
It is important to understand that having a particular genotype for rs2297595 does not provide a diagnosis or a definitive prediction of your health. Genetic variants like this one represent only a small piece of a much larger puzzle that includes your overall genetic background, lifestyle, diet, and environment. Because the evidence linking this variant to specific health outcomes is limited and often mixed, it is not currently used in routine clinical practice to guide medical decisions. If you have questions about your health, inflammatory conditions, or how your body responds to infections, the best course of action is to consult with a qualified healthcare professional. They can provide context based on your personal medical history and current clinical guidelines. Never use genetic information to make changes to your medications or health regimen without first discussing it with your doctor or pharmacist.
How common is this variant?
The rs2297595 variant is common, with a minor allele frequency of approximately 0.15 to 0.30 across diverse global populations.
Frequently asked questions
What does the NOS2 gene do?
The NOS2 gene provides instructions for making the inducible nitric oxide synthase enzyme. This enzyme is activated by the immune system to produce nitric oxide, which helps fight infections and regulate inflammation.
Is rs2297595 linked to malaria?
Some research has investigated whether variants in the NOS2 gene, including rs2297595, influence susceptibility to severe malaria. While there are associations with nitric oxide production, the evidence remains limited and inconsistent across different studies.
Should I be worried about my rs2297595 genotype?
No, there is no reason for concern. This is a common genetic variant, and its presence does not indicate a disease or a specific health risk. It is simply a natural variation in the human genome.
Can I use this information to change my diet or supplements?
No. You should never use genetic information to alter your diet or supplement intake without consulting a healthcare professional. Genetic associations are complex and do not provide enough information to justify specific medical or nutritional interventions.
Sources & further reading
Educational information only, last refreshed 10/16/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2297595?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in NOS2
This variant in the inducible nitric oxide synthase gene is associated with systemic inflammation and nitric oxide metabolite levels.
Variant in the nitric oxide synthase 2 gene associated with altered susceptibility to age-related macular degeneration (AMD).
Functional polymorphism interacting with environmental factors such as smoking to modify the risk of age-related macular degeneration.